HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,273,000 | -63.1% | 1,230,399 | -3.9% | 0.39% | -58.4% |
| Q1 2017 | $8,859,000 | +208.9% | 1,280,185 | 0.0% | 0.94% | +245.4% |
| Q4 2016 | $2,868,000 | -1.3% | 1,280,185 | 0.0% | 0.27% | +5.8% |
| Q3 2016 | $2,906,000 | -16.5% | 1,280,185 | 0.0% | 0.26% | -29.5% |
| Q2 2016 | $3,482,000 | -5.2% | 1,280,185 | 0.0% | 0.37% | -9.2% |
| Q1 2016 | $3,674,000 | -34.2% | 1,280,185 | 0.0% | 0.40% | -25.0% |
| Q4 2015 | $5,582,000 | -42.8% | 1,280,185 | 0.0% | 0.54% | -46.7% |
| Q3 2015 | $9,755,000 | -31.7% | 1,280,185 | 0.0% | 1.01% | -1.9% |
| Q2 2015 | $14,274,000 | – | 1,280,185 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
| Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
| Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
| HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
| Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
| Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
| WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
| Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
| Virtu Financial LLC | 12,049 | $4,000 | 0.00% |